Market Tracker

08/29 2:04pm ET

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.65
Data as of 1:48pm ET
 +0.0899 / +5.76%
Today’s Change
0.78
Today|||52-Week Range
1.75
+42.23%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close1.56
Today’s open1.60
Day’s range1.60 - 1.75
Volume1,410,810
Average volume (3 months)613,861
Market cap$68.8M
Dividend yield--
Data as of 1:48pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-241.48%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-19.03%
P/E ratio2.8
Price/Sales1.47
Price/Book13.09

Competitors

 Today’s
change
Today’s
% change
OGXIOncoGenex Pharmaceut...+0.01+0.30%
AVEOAveo Pharmaceuticals...+0.03+2.33%
CPXXCelator Pharmaceutic...+0.05+1.85%
IMMYImprimis Pharmaceuti...+0.08+1.03%
Data as of 1:46pm ET, 08/29/2014

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$34.5M
Annual profit (last year)$18.2M
Net profit margin52.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Operating Officer
George W. Hebard
Chief Financial Officer &
Vice President-Finance
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts